Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 3, 2004. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share buyback transaction:
- Shares Purchased: 890,000 Ordinary 25 pence shares.
- Transaction Date: March 2, 2004.
- Price per Share: 1,120.69 pence.
- Transaction Purpose: Purchase for cancellation.
Material Changes
The filing does not disclose material changes in financial performance compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 890,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items beyond the execution of the authorized share buyback.
Investor Verification Checklist
- Verify the total number of shares remaining outstanding following the cancellation of 890,000 shares.
- Confirm the total cash outflow for the repurchase (890,000 shares x 1,120.69 pence).
- Review the full Annual General Meeting minutes from May 19, 2003, to understand the remaining authority for future share buybacks.